Unlock instant, AI-driven research and patent intelligence for your innovation.

Compounds, reagents, and uses thereof

A compound, deuteration technology, applied in the field of compounds, reagents and their uses, can solve problems such as unknown structure and limited practicability

Pending Publication Date: 2020-07-10
麦特博隆股份有限公司
View PDF6 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

The previously identified analyte / marker was X-11564, a marker associated with GFR and renal function, but its structure was unknown, which limited its usefulness

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Compounds, reagents, and uses thereof
  • Compounds, reagents, and uses thereof
  • Compounds, reagents, and uses thereof

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0313] Example 1. Structural Elucidation of Plasma and Urine Metabolite Compound A

[0314] Sample Preparation

[0315] Add 6 mL of pooled human plasma and 30 mL of methanol to a 50 mL plastic centrifuge tube. The mixture was vortexed for about 1 minute and centrifuged at 4000 rpm for 15 minutes at 4°C. The supernatant was transferred to a 96-well plate at 500 μL per well and dried at 40° C. under a gentle flow of nitrogen. The residues in 5 wells were reconstituted sequentially in water (200 mL) under vortexing (1 min each). The mixture was then transferred to a 1.5 mL Eppendorf tube and centrifuged at 14,000 rpm for 10 minutes at room temperature. The supernatant was then transferred to vials for LC / MS analysis. Urine samples were centrifuged at 14,000 rpm for 10 minutes at room temperature, and the supernatant (diluted with water if necessary) was transferred to vials for LC / MS analysis. Regarding the retention time comparison of Compound A in plasma and urine samples,...

Embodiment 2

[0356] Example 2. Synthesis of (2R,3R)-2,3-dihydroxy-5-methylthio-trans-4-pentenoic acid (trans-DMTPA)

[0357] method 1.

[0358] Wittig reaction

[0359] (Methylthiomethyl)triphenylphosphonium chloride (500 mg, 1.39 mmol, 2.2 equiv) was suspended in tetrahydrofuran in a 25 mL round bottom flask under argon atmosphere. The mixture was cooled to 0° C., and sodium bis(trimethylsilyl)amide (1.0 M in tetrahydrofuran, 1.39 mL, 1.39 mmol, 2.2 eq.) was added slowly while the mixture was stirred. The resulting mixture was stirred at 0 °C for another 30 minutes, and 2,3-cyclohexylene-L-erythuronic acid (136 mg in 1.0 mL tetrahydrofuran, 0.633 mmol, 1.0 equiv) was added slowly. After 5 minutes, the reaction mixture was warmed to room temperature and stirred overnight. The reaction mixture was transferred to NaH 2 PO 4 aqueous solution (1.0 M, 25 mL), and the resulting mixture (pH~6.0) was extracted with ethyl acetate (2 x 40 mL). The combined organic extracts were dried (MgSO 4 ...

Embodiment 3

[0373] Example 3. LC-MS / MS Measurement of Compound A

[0374] Reversed-phase columns (Waters ACQUITY BEH C18, 1.7 μm, 2.1 x 100 mm) liquid chromatography. Mobile phase A was 0.1% formic acid in water and mobile phase B was 0.1% formic acid in acetonitrile. Linear gradient elution was performed with an initial condition of 2% mobile phase B (hold it for 3.00 minutes). Mobile phase B was then increased to 98% over 0.40 minutes and held for 0.50 minutes. Return mobile phase B to 2% over 0.10 minutes for the next injection to equilibrate. The total run time is 5.00 minutes. For each sample, inject a 5.0 µL ring-fixed aliquot of the final sample solution. The flow rate was 350 μL / min and the eluent was introduced directly into the electrospray source of the mass spectrometer. The strong needle wash (200 μL) is pure methanol, and the weak needle wash (600 μL) is a mixture of methanol and water (0.5:99.5). The seal wash solution is a mixture of methanol and water (10:90).

...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The present invention provides a compound of formula (I), formula (II), formula (III), (IV) or a salt thereof, compositions and methods of making the compound, methods and reagents for measuring the compound, and kits using the same. The use of a compound of formula (I), formula (II), formula (III), or formula (IV) for assessing or monitoring kidney function in a subject, determining predisposition to developing reduced kidney function, classifying a subject according to level of kidney function, and diagnosing or monitoring chronic kidney disease is also described.

Description

[0001] related application [0002] This application claims the benefit of the filing date of U.S. Provisional Application No. 62 / 564,558 filed September 28, 2017 under 35 U.S.C. § 119(e), the entire contents, including all drawings, formulas, description and claims) are incorporated herein by reference. Background technique [0003] The following information describing the background of the invention is provided to aid in the understanding of the invention and is not considered to constitute or describe prior art to the present invention. [0004] Kidney function is traditionally assessed using glomerular filtration rate (GFR). Although the gold standard method, measured GFR (mGFR), is precise and accurate, its utility is limited by the complex, time-consuming, and invasive nature of the assay. It is also an expensive experiment to perform. Therefore, GFR is estimated clinically using an equation based on the concentrations of the endogenous filtration markers creatinine ...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Applications(China)
IPC IPC(8): G01N33/68C07C69/52
CPCC07C201/00C07C319/12C07C323/54G01N33/6848G01N33/6893C07C319/18C07K16/44G01N30/7233
Inventor 张启博
Owner 麦特博隆股份有限公司